Browsing Tag
ADARx Pharmaceuticals
2 posts
ADARx Pharmaceuticals jumps in Nasdaq debut after upsized $446.3m IPO
ADARx Pharmaceuticals has completed one of the larger biotechnology flotations of 2026, pricing an upsized $446.3 million Nasdaq offering at the top of its range before shares opened 30% above the IPO price.
ADARx IPO grows to $446m as RNA drug developer targets Nasdaq debut
ADARx Pharmaceuticals has priced an enlarged U.S. IPO at $17 a share, generating about $446.3 million before expenses, while AbbVie plans a concurrent investment that would give it roughly 4.9% ownership.